Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.23.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 75,518 $ 47,515
Restricted cash 4,350 4,272
Financing receivables, net of allowance for credit losses 21,299 48,925
Intangible assets, net 312,589 319,920
Property and equipment, net 1,383 1,489
Other assets 35,286 30,074
Total assets 450,425 452,195
Liabilities    
Accounts payable and accrued expenses 51,306 20,674
Funding commitments 29,378 20,400
Debt 7,694 20,613
Deferred tax liabilities 688 688
Warrants, at fair value 931 4,297
Other liabilities 23,788 17,196
Total liabilities 113,785 83,868
Commitments and Contingencies (Note 10)
Stockholders' Equity    
Preferred stock 0 0
Additional paid-in capital 747,064 761,698
Accumulated deficit (524,285) (501,635)
Total capital 222,788 260,071
Treasury stock, at cost; 16,459 and 1,312,155 Class A shares as of March 31, 2023 and December 31, 2022, respectively (17) (15,307)
Total stockholders' equity 222,771 244,764
Noncontrolling interests in consolidated subsidiaries 113,869 123,563
Total equity 336,640 368,327
Total liabilities and stockholders' equity 450,425 452,195
Advances (net of allowance for credit losses of $2,319 and $6,736)    
Assets    
Financing receivables, net of allowance for credit losses 18,030 45,393
Financing receivables (net of allowance for credit losses of $151 and $102)    
Assets    
Financing receivables, net of allowance for credit losses 3,269 3,532
Class A Common Stock    
Stockholders' Equity    
Common stock 9 8
Class C Common Stock    
Stockholders' Equity    
Common stock $ 0 $ 0